Variable . | n . | Male subjects (n = 358) . | n . | Female subjects (n = 378) . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariate . | Multivariate* . | Univariate . | Multivariate‡ . | |||||||
OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . | |||
LDRa | ||||||||||
Quartile 1(<19.8) | 91 | 1.8 (1.1–2.9) | 0.01 | 2.1 (1.1–4.0) | 0.03 | 93 | 2.0 (1.1–3.7) | 0.02 | 1.7 (1.1–2.7) | 0.03 |
Quartile 2 (19.8–65.6) | 96 | 0.9 (0.5–1.5) | 0.7 | 2.7 (1.4–5.5) | 0.004 | 88 | 2.0 (1.1–3.7) | 0.02 | 0.8 (0.5–1.4) | 0.5 |
Quartile 3 (65.6–114.2) | 87 | 1.0 (0.6–1.6) | 0.9 | 2.2 (1.1–4.4) | 0.03 | 97 | 1.6 (0.9–3.0) | 0.1 | 1.0 (0.6–1.6) | 0.8 |
Quartile 4 (>114.2) | 84 | Reference | Reference | 100 | Reference | Reference | ||||
STa (×103) | ||||||||||
Quartile 1 (<1,091) | 89 | Reference | Reference | 95 | Reference | Reference | ||||
Quartile2 (1,091–1,107) | 93 | 1.8 (1.1–3.1) | 0.03 | 2.4 (1.3–4.2) | 0.003 | 91 | 1.3 (0.8–2.1) | 0.3 | 1.2 (0.7–2.0) | 0.6 |
Quartile 3 (1,108–1,127) | 94 | 1.6 (0.9–2.8) | 0.1 | 2.0 (1.1–3.6) | 0.02 | 90 | 1.5 (0.9–2.5) | 0.08 | 1.4 (0.9–2.2) | 0.2 |
Quartile 4 (>1,127) | 82 | 2.1 (1.2–3.6) | 0.01 | 2.4 (1.1–4.4) | 0.007 | 102 | 1.3 (0.8–2.2) | 0.2 | 1.1 (0.7–1.8) | 0.8 |
Diabetes duration (years) | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.0–1.3) | <0.001 | ||
A1C | 1.2 (1.0–1.3) | 0.03 | 1.2 (1.1–1.4) | 0.001 | 0.9 (0.8–1.0) | 0.2 | — | |||
Cholesterol | 1.4 (1.2–1.7) | 0.001 | 1.3 (1.1–1.5) | 0.01 | 1.0 (0.8–1.2) | 0.7 | — | |||
DBP (mmHg) | 1.05 (1.03–1.07) | <0.001 | 1.04 (1.02–1.06) | 0.001 | 1.01 (1.00–1.03) | 0.1 | — | |||
BMI (kg/m2) | 1.09 (1.04–1.13) | <0.001 | — | — | 1.14 (1.08–1.19) | <0.001 | 1.07 (1.03–1.12) | 0.001 |
Variable . | n . | Male subjects (n = 358) . | n . | Female subjects (n = 378) . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariate . | Multivariate* . | Univariate . | Multivariate‡ . | |||||||
OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . | |||
LDRa | ||||||||||
Quartile 1(<19.8) | 91 | 1.8 (1.1–2.9) | 0.01 | 2.1 (1.1–4.0) | 0.03 | 93 | 2.0 (1.1–3.7) | 0.02 | 1.7 (1.1–2.7) | 0.03 |
Quartile 2 (19.8–65.6) | 96 | 0.9 (0.5–1.5) | 0.7 | 2.7 (1.4–5.5) | 0.004 | 88 | 2.0 (1.1–3.7) | 0.02 | 0.8 (0.5–1.4) | 0.5 |
Quartile 3 (65.6–114.2) | 87 | 1.0 (0.6–1.6) | 0.9 | 2.2 (1.1–4.4) | 0.03 | 97 | 1.6 (0.9–3.0) | 0.1 | 1.0 (0.6–1.6) | 0.8 |
Quartile 4 (>114.2) | 84 | Reference | Reference | 100 | Reference | Reference | ||||
STa (×103) | ||||||||||
Quartile 1 (<1,091) | 89 | Reference | Reference | 95 | Reference | Reference | ||||
Quartile2 (1,091–1,107) | 93 | 1.8 (1.1–3.1) | 0.03 | 2.4 (1.3–4.2) | 0.003 | 91 | 1.3 (0.8–2.1) | 0.3 | 1.2 (0.7–2.0) | 0.6 |
Quartile 3 (1,108–1,127) | 94 | 1.6 (0.9–2.8) | 0.1 | 2.0 (1.1–3.6) | 0.02 | 90 | 1.5 (0.9–2.5) | 0.08 | 1.4 (0.9–2.2) | 0.2 |
Quartile 4 (>1,127) | 82 | 2.1 (1.2–3.6) | 0.01 | 2.4 (1.1–4.4) | 0.007 | 102 | 1.3 (0.8–2.2) | 0.2 | 1.1 (0.7–1.8) | 0.8 |
Diabetes duration (years) | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.2–1.3) | <0.001 | 1.2 (1.0–1.3) | <0.001 | ||
A1C | 1.2 (1.0–1.3) | 0.03 | 1.2 (1.1–1.4) | 0.001 | 0.9 (0.8–1.0) | 0.2 | — | |||
Cholesterol | 1.4 (1.2–1.7) | 0.001 | 1.3 (1.1–1.5) | 0.01 | 1.0 (0.8–1.2) | 0.7 | — | |||
DBP (mmHg) | 1.05 (1.03–1.07) | <0.001 | 1.04 (1.02–1.06) | 0.001 | 1.01 (1.00–1.03) | 0.1 | — | |||
BMI (kg/m2) | 1.09 (1.04–1.13) | <0.001 | — | — | 1.14 (1.08–1.19) | <0.001 | 1.07 (1.03–1.12) | 0.001 |
In addition to LDR and ST:
*Male multivariate model included diabetes duration, A1C, total cholesterol, and DBP as significant covariates.
‡Female multivariate model included diabetes duration and BMI as significant covariates.